RecruitingNCT06408441

The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)

Studying Epithelioid hemangioendothelioma

Last synced from ClinicalTrials.gov May 8, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Enrollment: 100 enrolled
Eligibility: 18 years · All sexes
Timeline: 2023 – 2033

Study locations (21)

University Hospital Graz, Graz, Graz, Austria
Aarhus University Hospital, Aarhus, Aarhus, Denmark
Léon Bérard Center, Lyon, Lyon, France
Essen University Hospital, Essen, Hesse, Germany
Istituto Ortopedico Rizzoli, Bologna, Bologna, Italy
Azienda Ospedaliero Universitaria Careggi, Careggi, Firenze, Italy
IRCCS Istituto Clinica Humanitas, Rozzano, Milano, Italy
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Milan, Italy
Istituto Oncologico Veneto, Padua, Padova, Italy
Policlinico Universitario P. Giaccone, Palermo, Palermo, Italy
Nuovo Ospedale di Prato "S.Stefano", Prato, Prato, Italy
Università Campus Bio-Medico, Roma, Roma, Italy
Istituto Nazionale dei Tumori Regina Elena, Roma, Roma, Italy
Azienda Ospedaliera Universitaria San Luigi Gonzaga, Orbassano, Torino, Italy
Oslo University hospital Ullevål, Oslo, Oslo County, Norway
+6 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06408441 on ClinicalTrials.gov

Other trials for Epithelioid hemangioendothelioma

Additional recruiting or active studies for the same condition.

See all trials for Epithelioid hemangioendothelioma →

← Back to all trials